Deepika Sirohi

Deepika Sirohi, MD, is an Associate Professor in the Department of Pathology at the University of California, San Francisco (UCSF). She specializes in Genitourinary and Molecular Pathology with a focus on tumors of the kidney, prostate, urinary bladder, and testis. Her research emphasizes the molecular biology of renal tumors and prostate carcinoma, including the study of rare and common subtypes of kidney tumors. Dr. Sirohi is affiliated with the Clinical Cancer Genomics Laboratory at UCSF, contributing to cutting-edge molecular diagnostics and translational research.

Her work spans genomic and molecular analyses of tumors, including studies on histologic patterns in renal cell carcinoma and their prognostic implications, as well as interrater agreement in variant classification. She has explored the utility of advanced techniques like digital pathology and AI-based biomarkers in cancer diagnosis and prognosis. Dr. Sirohi’s research also addresses clinical challenges such as HER2 testing in breast cancer and the integration of genomic classifiers in prostate cancer management.

Dr. Sirohi has contributed to over 50 publications, focusing on topics like genomic profiling of tumors, molecular heterogeneity in urothelial carcinoma, and the clinical relevance of morphologic features in predicting outcomes. Her work bridges basic research and clinical practice, with a particular emphasis on improving diagnostic accuracy and patient care through molecular insights.